UCFA
MYGN icon

United Capital Financial Advisors’s Myriad Genetics MYGN Stock Holding History

United Capital Financial Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-267,875
Closed -$8.3M – 1295
2016
Q2 		$8.3M Buy
267,875
+6,388
+2% +$222K 0.08% 280
2016
Q1 		$9.79M Buy
261,487
+1,005
+0.4% +$37.9K 0.11% 207
2015
Q4 		$11.2M Buy
260,482
+528
+0.2% +$22.3K 0.13% 179
2015
Q3 		$9.74M Buy
259,954
+2,305
+0.9% +$81.8K 0.12% 195
2015
Q2 		$8.76M Buy
257,649
+7,933
+3% +$270K 0.1% 237
2015
Q1 		$8.25M Sell
249,716
-138,065
-36% -$4.94M 0.1% 253
2014
Q4 		$13.2M Sell
387,781
-45
-0% -$1.6K 0.2% 131
2014
Q3 		$15M Buy
387,826
+918
+0.2% +$34.3K 0.26% 99
2014
Q2 		$15.1M Buy
386,908
+2,495
+0.6% +$92.8K 0.28% 95
2014
Q1 		$13.1M Buy
384,413
+9,380
+3% +$291K 0.28% 84
2013
Q4 		$7.87M Buy
375,033
+318,035
+558% +$8.04M 0.27% 105
2013
Q3 		$1.34M Sell
56,998
-174,729
-75% -$4.96M 0.04% 305
2013
Q2 		$6.23M Buy
+231,727
New +$6.72M 0.17% 157

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

United Capital Financial Advisors's MYGN Position: Q3 2016 in Review

United Capital Financial Advisors sold out of Myriad Genetics (MYGN) in Q3 2016, closing a stake of 267,875 shares — an estimated $8.3M sold.

United Capital Financial Advisors first reported a position in MYGN in Q2 2013 and held it in 13 quarters. The position peaked at $15.1M in Q2 2014. 223 funds tracked by Wall St. Rank hold MYGN as of Q3 2016.

  • United Capital Financial Advisors reported no remaining Myriad Genetics position as of Q3 2016 after selling out during the quarter.
  • United Capital Financial Advisors sold 267,875 Myriad Genetics shares in Q3 2016, an estimated $8.3M.
  • United Capital Financial Advisors first reported a position in Myriad Genetics in Q2 2013 and held it in 13 quarters.
  • United Capital Financial Advisors's Myriad Genetics position peaked at $15.1M in Q2 2014.
  • 223 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2016.

Based on United Capital Financial Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.